Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study
This study was designed to evaluate the box sale trends of insulin preparations and glucagon-like peptide-1 (Glp-1) analogs by their therapeutic categories in Turkey. Also, we aimed to project sale trends of these pharmaceuticals in next years. We analyzed the data before the covid-19 pandemic and m...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sakarya University
2023-03-01
|
| Series: | Sakarya Tıp Dergisi |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/tr/download/article-file/2072432 |
| _version_ | 1797350396202582016 |
|---|---|
| author | Oğuzhan Yıldız Kemal Gökhan Ulusoy Çağıl Önal Sis İsmail Mert Vural |
| author_facet | Oğuzhan Yıldız Kemal Gökhan Ulusoy Çağıl Önal Sis İsmail Mert Vural |
| author_sort | Oğuzhan Yıldız |
| collection | DOAJ |
| description | This study was designed to evaluate the box sale trends of insulin preparations and glucagon-like peptide-1 (Glp-1) analogs by their therapeutic categories in Turkey. Also, we aimed to project sale trends of these pharmaceuticals in next years. We analyzed the data before the covid-19 pandemic and made predictions based on these data. This study analyzed retail and hospital box sales of insulin preparations from 4 therapeutic categories (fast/short-acting, intermediate-acting, premix, long-acting) and Glp-1 analogs. Total box sales of the insulin preparations were increased by %13,30 in the period examined. While fast/short-acting and long-acting insulin box sales increased with a decreasing upward trend, intermediate-acting and premix insulin box sales decreased. Glp-1 analog sales increased rapidly in this period. Currently, newer pharmaceuticals have been entering Turkish market for diabetes treatment. Less insulin might be required if newer pharmaceuticals are more widely available in diabetes treatment. Also it will be useful to evaluate the effect of the pandemic on access to pharmaceuticals used in the treatment of chronic diseases in future studies. |
| first_indexed | 2024-03-08T12:44:19Z |
| format | Article |
| id | doaj.art-504e0faa553b4f1689284e3da83b88e1 |
| institution | Directory Open Access Journal |
| issn | 2146-409X |
| language | English |
| last_indexed | 2024-03-08T12:44:19Z |
| publishDate | 2023-03-01 |
| publisher | Sakarya University |
| record_format | Article |
| series | Sakarya Tıp Dergisi |
| spelling | doaj.art-504e0faa553b4f1689284e3da83b88e12024-01-21T07:40:10ZengSakarya UniversitySakarya Tıp Dergisi2146-409X2023-03-01131485410.31832/smj.102131128Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis StudyOğuzhan Yıldız0Kemal Gökhan Ulusoy1Çağıl Önal Sis2İsmail Mert Vural3SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, GÜLHANE TIP FAKÜLTESİSAĞLIK BİLİMLERİ ÜNİVERSİTESİ, GÜLHANE TIP FAKÜLTESİSAĞLIK BİLİMLERİ ÜNİVERSİTESİ, GÜLHANE TIP FAKÜLTESİSAĞLIK BİLİMLERİ ÜNİVERSİTESİ, GÜLHANE ECZACILIK FAKÜLTESİ, GÜLHANE ECZACILIK PR.This study was designed to evaluate the box sale trends of insulin preparations and glucagon-like peptide-1 (Glp-1) analogs by their therapeutic categories in Turkey. Also, we aimed to project sale trends of these pharmaceuticals in next years. We analyzed the data before the covid-19 pandemic and made predictions based on these data. This study analyzed retail and hospital box sales of insulin preparations from 4 therapeutic categories (fast/short-acting, intermediate-acting, premix, long-acting) and Glp-1 analogs. Total box sales of the insulin preparations were increased by %13,30 in the period examined. While fast/short-acting and long-acting insulin box sales increased with a decreasing upward trend, intermediate-acting and premix insulin box sales decreased. Glp-1 analog sales increased rapidly in this period. Currently, newer pharmaceuticals have been entering Turkish market for diabetes treatment. Less insulin might be required if newer pharmaceuticals are more widely available in diabetes treatment. Also it will be useful to evaluate the effect of the pandemic on access to pharmaceuticals used in the treatment of chronic diseases in future studies.https://dergipark.org.tr/tr/download/article-file/2072432diyabetes mellitüsi̇nsülin satışları; glukagon benzeri peptid-1 analog satışlarıdiabetes mellitusinsulin salesglucagon-like peptide-1 analog sales |
| spellingShingle | Oğuzhan Yıldız Kemal Gökhan Ulusoy Çağıl Önal Sis İsmail Mert Vural Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study Sakarya Tıp Dergisi diyabetes mellitüs i̇nsülin satışları ; glukagon benzeri peptid-1 analog satışları diabetes mellitus insulin sales glucagon-like peptide-1 analog sales |
| title | Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study |
| title_full | Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study |
| title_fullStr | Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study |
| title_full_unstemmed | Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study |
| title_short | Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study |
| title_sort | evaluation of insulin and glucagon like peptide 1 analog sales in turkey before the pandemic period projection for upcoming years a market analysis study |
| topic | diyabetes mellitüs i̇nsülin satışları ; glukagon benzeri peptid-1 analog satışları diabetes mellitus insulin sales glucagon-like peptide-1 analog sales |
| url | https://dergipark.org.tr/tr/download/article-file/2072432 |
| work_keys_str_mv | AT oguzhanyıldız evaluationofinsulinandglucagonlikepeptide1analogsalesinturkeybeforethepandemicperiodprojectionforupcomingyearsamarketanalysisstudy AT kemalgokhanulusoy evaluationofinsulinandglucagonlikepeptide1analogsalesinturkeybeforethepandemicperiodprojectionforupcomingyearsamarketanalysisstudy AT cagılonalsis evaluationofinsulinandglucagonlikepeptide1analogsalesinturkeybeforethepandemicperiodprojectionforupcomingyearsamarketanalysisstudy AT ismailmertvural evaluationofinsulinandglucagonlikepeptide1analogsalesinturkeybeforethepandemicperiodprojectionforupcomingyearsamarketanalysisstudy |